Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer
Andrea Sheel(University of Liverpool), Eithne Costello(University of Liverpool), Jayapal Ramesh(University of Liverpool), Richard Jackson(University of Liverpool), Michael Raraty(University of Liverpool), Paula Ghaneh(University of Liverpool), William Greenhalf(University of Liverpool), Ioannis Sarantitis(University of Liverpool), Christopher Grocock(University of Liverpool), Stephen P. Pereira(The Royal Free Hospital), Pascal Hammel(Hôpital Paul-Brousse), Andrew M. Smith(Leeds Teaching Hospitals NHS Trust), R. Mountford(University of Liverpool), C. McKay(University of Southampton), Christopher Halloran(University of Liverpool), Guruprasad P. Aithal(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Michael H. Chapman(University College London), Markus M. Lerch(Ludwig-Maximilians-Universität München), James Nicholson(University of Liverpool), Sara Harrison(University of Liverpool), Thomas Hanna(University of Liverpool), R. Carter(Cancer Research UK), Zaed Hamady(University Hospital Southampton NHS Foundation Trust), A. Farooq(University of Liverpool)
Cited by 33
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k